Effect of ascorbic acid and alpha-tocopherol supplementations on serum leptin, tumor necrosis factor alpha, and serum amyloid A levels in individuals with type 2 diabetes mellitus

Document Type : Original Research Article


1 Department of Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 Biotechnology Research Center, Research Institute of Petroleum Industry (RIPI), Tehran, Iran

3 Cellular and Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran


Objective: Diabetes mellitus Type 2 is one of the most widespread chronic metabolic diseases. In most cases, this type of diabetes is associated with alterations in levels of some inflammatory cytokines and hormones. Considering anti-inflammatory properties of plant extracts rich in ascorbic acid (vitamin C) and alpha-tocopherol (vitamin E), anti-diabetic properties of these two well-known antioxidant vitamins were investigated through measurement of serum levels of high-sensitivity C-reactive protein (hs-CRP), insulin, leptin, tumor necrosis factor alpha (TNF-α), and serum amyloid A (SAA) in patients with diabetes mellitus type 2.
Methods: Male patients (n=80) were randomly divided into two groups each consisted of 40 subjects. Test groups were supplemented with ascorbic acid (1000 mg/day) or alpha-tocopherol (300 mg/day) orally during four weeks. Before and after treatment, serum biochemical factors of subjects were measured and compared.
Results: Our results showed that both ascorbic acid and alpha-tocopherol could induce significant anti-inflammatory effects by decreasing the level of inflammatory factors such as TNF-α, SAA, and hs-CRP in diabetes mellitus type 2 patients. Effects of alpha-tocopherol and ascorbic acid in decreasing serum leptin level were similar. Ascorbic acid in contrast to alpha-tocopherol diminished fasting insulin and HOMA index but had no effect on LDL serum level.
Conclusion: Concerning the obtained results, it is concluded that consumption of supplementary vitamins C and E could decrease induced inflammatory response in patients with diabetes mellitus type 2.  It is also possible that vitamin C and vitamin E supplementation can attenuate incidence of some proposed pathological effects of diabetes mellitus.


Main Subjects

Afkhami-Ardekani M, Shojaoddiny- Ardekani A. 2007. Effect of vitamin C on blood glucose, serum lipids & serum insulin in type 2 diabetes patients. Indian J Med Res, 126: 471-474.
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. 2006. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw, 17: 4-12.
Biniaz V, Sadeghi Shermeh M, Ebadi A, Tayebi A, Einollahi B. 2014. Effect of vitamin C supplementation on C-reactive protein levels in patients undergoing hemodialysis: A randomized, double blind, placebo-controlled study. Nephrourol Mon, 6: e13351.
Brennan AM, Mantzoros CS. 2006. Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications. Nat Clin Pract Endocrinol Metab, 2: 318-327.
Calder PC, Albers R, Antoine JM, Blum S, Bourdet-Sicard R, Ferns GA, Folkerts G, Friedmann PS, Frost GS, Guarner F, Lovik M, Macfarlane S, Meyer PD, M'Rabet L, Serafini M, van Eden W, van Loo J, Vas Dias W, Vidry S, Winklhofer-Roob BM, Zhao J. 2009. Inflammatory disease processes and interactions with nutrition. Br J Nutr 101 Suppl 1: S1-45.
Chen Y, Luo G, Yuan J, Wang Y, Yang X, Wang X, Li G, Liu Z, Zhong N. 2014. Vitamin C mitigates oxidative stress and tumor necrosis factor-alpha in severe community-acquired pneumonia and LPS-induced macrophages. Mediators Inflamm, 2014: 426740.
DePaoli A. 2014. Leptin in common obesity and associated disorders of metabolism. J Endocrinol, 223: T71-81.
Devaraj S, Jialal I. 2000. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med, 29: 790-792.
Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR,Heiss G. 2003. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52: 1799-1805.
Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. 2014. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract, 105: 141-150.
Felipe F, Mercader J, Ribot J, Palou A, Bonet ML. 2005. Effects of retinoic acid administration and dietary vitamin A supplementation on leptin expression in mice: lack of correlation with changes of adipose tissue mass and food intake. Biochim Biophys Acta, 1740: 258-265.
Fischer S, Hanefeld M, Haffner SM, Fusch C, Schwanebeck U, Kohler C, Fucker K, Julius U. 2002. Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass. Acta Diabetol, 39: 105-110.
Fuller CJ, May MA, Martin KJ. 2000. The effect of vitamin E and vitamin C supplementation on LDL oxidizability and neutrophil respiratory burst in young smokers. J Am Coll Nutr, 19: 361-369.
Garcia-Diaz DF, Campion J, Milagro FI, Boque N, Moreno-Aliaga MJ, Martinez JA. 2010. Vitamin C inhibits leptin secretion and some glucose/lipid metabolic pathways in primary rat adipocytes. J Mol Endocrinol, 45: 33-43.
Gimeno RE, Klaman LD. 2005. Adipose tissue as an active endocrine organ: recent advances. Curr Opin Pharmacol, 5: 122-128.
Ginter E, Cerna O, Budlovsky J, Balaz V, Hruba F, Roch V, Sasko E. 1977. Effect of ascorbic acid on plasma cholesterol in humans in a long-term experiment. Int J Vitam Nutr Res, 47: 123-134.
Gonzalez Y, Herrera MT, Soldevila G, Garcia-Garcia L., Fabian G., Perez-Armendariz EM, Bobadilla K, Guzman-Beltran S, Sada E, Torres M. 2012. High glucose concentrations induce TNF-alpha production through the down-regulation of CD33 in primary human monocytes. BMC Immunol, 13: 19.
Haffner SM. 2006. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol, 97: 3A-11A.
Hollung K, Rise CP, Drevon CA, Reseland JE. 2004. Tissue-specific regulation of leptin expression and secretion by all-trans retinoic acid. J Cell Biochem, 92: 307-315.
Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J. 2010. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet, 375: 132-140.
Kaur J. 2014. A comprehensive review on metabolic syndrome. Cardiol Res Pract, 2014: 943162.
Kieffer TJ, Heller RS,Habener JF. 1996. Leptin receptors expressed on pancreatic beta-cells. Biochem Biophys Res Commun, 224: 522-527.
Lai MH. 2008. Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and E supplementation for type 2 diabetes mellitus. J Clin Biochem Nutr, 43: 191-198.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28: 412-419.
McNeely MJ, Boyko EJ, Weigle DS, Shofer JB, Chessler SD, Leonnetti DL, Fujimoto WY. 1999. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care, 22: 65-70.
McRae MP. 2008. Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials. J Chiropr Med, 7: 48-58.
Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA. 2003. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int J Obes Relat Metab Disord, 27: 88-94.
Moller DE. 2000. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab, 11: 212-217.
Myasnikov AL. 1958. Influence of some factors on development of experimental cholesterol atherosclerosis. Circulation 17: 99-113.
Nishimura S, Manabe I, Nagai R. 2009. Adipose tissue inflammation in obesity and metabolic syndrome. Discov Med, 8: 55-60.
Pickup JC, Chusney GD, Thomas SM, Burt D. 2000. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci, 67: 291-300.
Reaven PD, Herold DA, Barnett J, Edelman S. 1995. Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care, 18: 807-816.
Rho YH, Chung CP, Oeser A, Solus J, Asanuma Y, Sokka T, Pincus T, Raggi P, Gebretsadik T, Shintani A. 2009. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum, 61: 1580-1585.
Samuel P, Shalchi OB. 1964. Effect of Vitamin C on Serum Cholesterol in Patients with Hypercholesterolemia and Arteriosclerosis. Circulation, 29: 24-25.
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J. 2010. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet, 375: 2215-2222.
Scheja L, Heese B, Zitzer H, Michael MD, Siesky AM, Pospisil H, Beisiegel U, Seedorf K. 2008. Acute-phase serum amyloid A as a marker of insulin resistance in mice. Exp Diabetes Res, 2008: 230837.
Shadman Z, Taleban FA, Saadat N, Hedayati M. 2013. Effect of conjugated linoleic acid and vitamin E on glycemic control, body composition, and inflammatory markers in overweight type2 diabetics. J Diabetes Metab Disord, 12: 42.
Singh U, Devaraj S, Jialal I. 2005. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr, 25: 151-174.
Swaroop JJ, Rajarajeswari D, Naidu JN. 2012. Association of TNF-alpha with insulin resistance in type 2 diabetes mellitus. Indian J Med Res, 135: 127-130.
Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark F T, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA,Tepper RI. 1995. Identification and expression cloning of a leptin receptor, OB-R. Cell, 83: 1263-1271.
Tong J, Fujimoto WY, Kahn SE, Weigle DS, McNeely MJ, Leonetti DL, Shofer JB, Boyko EJ. 2005. Insulin, C-peptide, and leptin concentrations predict increased visceral adiposity at 5- and 10-year follow-ups in nondiabetic Japanese Americans. Diabetes, 54: 985-990.
Uhlar CM, Whitehead AS. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem, 265: 501-523.
Vincent HK, Bourguignon CM, Weltman AL, Vincent KR, Barrett E, Innes KE,Taylor AG. 2009. Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults. Metabolism, 58: 254-262.
Wallace TM, Matthews DR. 2002. The assessment of insulin resistance in man. Diabet Med, 19: 527-534.
Williams KW, Scott MM, Elmquist JK. 2009. From observation to experimentation: leptin action in the mediobasal hypothalamus. Am J Clin Nutr, 89: 985S-990S.
Wu JH, Ward NC, Indrawan AP, Almeida CA, Hodgson JM, Proudfoot JM, Puddey IB, Croft KD. 2007. Effects of alpha-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes. Clin Chem, 53: 511-519.
Yudkin JS. 2003. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord, 27 Suppl 3: S25-28.